Coming of age for CDK 4/6 inhibitors: Interactive session and close

Share :
Sorry, this item is currently unavailable.
Published: 26 Oct 2016
Views: 1975
Dr Giuesppe Curigliano - European Institute of Oncology, Milan, Italy

Dr Curigliano chairs this closing session at the 'Coming of age for CDK 4/6 inhibitors' symposium at ESMO 2016.

He reaffirms the key take-home messages for breast oncologists and support professionals in this interactive question and answer session.

Supported by a grant from Pfizer Inc.